HSD17B13-IN-3
Product Specifications
UNSPSC Description
HSD17B13-IN-3 (compound 2) is a potent hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13) inhibitor. HSD17B13-IN-3 does not have cell experimental activity[1].
Target Antigen
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-3.html
Solubility
DMSO : 260 mg/mL (ultrasonic)
Smiles
CC1=C(S(C2=CC=C(C)C=C2)(=O)=O)C=C(C)C=C1S(=O)(NC3=CC=C(C(O)=O)C=C3)=O
Molecular Weight
459.54
References & Citations
[1]Liu S, et, al. Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13. Nat Commun. 2023 Aug 24;14(1):5158.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156736/HSD17B13-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156736/HSD17B13-IN-3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
313259-88-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal IgE Antibody (4H10) [PE/Cy7]](https://cdn.genprice.uk/genprice/genprice4.png)
MBS6272428-01 0.1 mL
AIM1L, CT (AIM1L, CRYBG2, Absent in melanoma 1-like protein, Beta/gamma crystallin domain-containing protein 2) (MaxLight 550)
Ask
View Details MBS6272428-02 5x 0.1 mL
AIM1L, CT (AIM1L, CRYBG2, Absent in melanoma 1-like protein, Beta/gamma crystallin domain-containing protein 2) (MaxLight 550)
Ask
View Details 